PDL BioPharma (PDLI) Misses Q1 EPS by 8c, Miss on Revenues
Tweet
Share
E-mailGet Alerts PDLI Hot Sheet
Price: $2.47 --0%
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
INLB, FTXP, EDXC, More
Financial Fact:
Income tax expense: 14.4M
Today's EPS Names:
INLB, FTXP, EDXC, More
Join SI Premium – FREE
PDL BioPharma (NASDAQ: PDLI) reported Q1 EPS of $0.01, $0.08 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $38.5 million versus the consensus estimate of $56.9 million.
For earnings history and earnings-related data on PDL BioPharma (PDLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blue Owl leads $2.4 billion debt deal for Iren data center
- SentinelOne, Inc. (S) Tops Q2 EPS by 1c; offers guidance
- HealthEquity (HQY) Tops Q2 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
